Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05023304 · ClinicalTrials.gov registry record · Phase 4
In Clinic Optometrist Insertion of Dextenza Prior to Cataract Surgery
A Phase 4 study, sponsored by Vance Thompson Vision.
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
NCT05023304 is a Phase 4 study that has completed, run by Vance Thompson Vision. The registered enrollment target is 30 participants.
The verdict
NCT05023304, a Phase 4 study, has completed, sponsored by Vance Thompson Vision.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
Study Summary
To evaluate the clinical outcomes with optometrist pre-surgical insertion of DEXTENZA in the clinical office setting in patients undergoing same-day cataract surgery compared to standard of care steroid therapy.
Interventions
- DRUG Dextenza 0.4Mg Ophthalmic Insert
- DRUG Topical prednisolone acetate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-08-23 |
| Est. Completion | 2022-10-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05023304
The ClinicalTrials.gov registry entry for NCT05023304 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vance Thompson Vision, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dextenza 0.4Mg Ophthalmic Insert is the first listed.
NCT05023304 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05023304 about?
NCT05023304 is a clinical study titled "In Clinic Optometrist Insertion of Dextenza Prior to Cataract Surgery". To evaluate the clinical outcomes with optometrist pre-surgical insertion of DEXTENZA in the clinical office setting in patients undergoing same-day cataract surgery compared to standard of care steroid therapy.
What is the current status of trial NCT05023304?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2021-08-23. Estimated completion is 2022-10-01.
What interventions are being tested in trial NCT05023304?
The interventions under investigation include: Dextenza 0.4Mg Ophthalmic Insert (DRUG), Topical prednisolone acetate (DRUG).
Who is sponsoring clinical trial NCT05023304?
This trial is sponsored by Vance Thompson Vision, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.